Navigation Links
Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
Date:3/6/2008

LAKE FOREST, Ill., March 6 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that Thomas E. Werner, senior vice president, Finance, and chief financial officer, will make a formal presentation at the Bear Stearns 10th Annual London Healthcare Conference on Thursday, March 13, 2008, at the Andaz London Hotel.

The presentation will be accessible to all interested parties at 9:30 a.m. Greenwich Mean Time (4:30 a.m. U.S. Central time) on Thursday, March 13, 2008, through a live audiocast in the investor relations section of Hospira's Web site at http://www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the audiocast. The slides accompanying the presentation will be available on the Hospira Web site beginning at 9:15 a.m. Greenwich Mean Time (4:15 a.m. U.S. Central time). A replay will be available on the Hospira Web site approximately 24 hours after the live presentation until March 20.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hos
'/>"/>

SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
2. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
3. Hospira Reports Third-Quarter 2007 Results
4. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
5. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
6. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
7. Hospira Launches Generic Irinotecan Injection
8. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
9. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
10. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
11. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... substantial proportion of risk for developing autism spectrum disorders ... interconnected biological pathways, according to researchers from the Icahn ... broad study of almost 2,500 families in the United ... "Convergence of Genes and Cellular Pathways Dysregulated in Autism ... American Journal of Human Genetics on April 24. ...
(Date:4/24/2014)... Scientific research at UT Southwestern Medical Center previously ... completely, whereas the adult heart lacks this ability. New ... the heart loses its incredible regenerative capability in adulthood, ... , Yes, oxygen. It is well-known that a major ... throughout the body. But at the same time, oxygen ...
(Date:4/24/2014)... Changes in managing patients before, during and after colorectal ... readmission rates, according to researchers who led a study ... practice, called enhanced recovery, is easier on patients before ... evacuation that are typically prescribed. After surgery, patients are ... possible, leading to faster recoveries. , Among findings published ...
(Date:4/24/2014)... terminology, and the relevance of palliation in advanced ... randomized controlled trials (RCTs). This is the result ... Quality and Efficiency in Health Care (IQWiG), which ... Together with external experts, IQWiG analysed studies on ... malignant melanoma, and pancreatic cancer. For this purpose, ...
(Date:4/24/2014)... A Finnish team of researchers was the first in ... which is a tumour of the jaw. , Ameloblastoma ... recur after treatment. Ameloblastoma is most often found in ... by surgery, often resulting in tissue deficiencies in the ... suitable drug therapy could reduce the need for surgery ...
Breaking Medicine News(10 mins):Health News:Genetic alterations in shared biological pathways as major risk factor for ASD 2Health News:Oxygen diminishes the heart's ability to regenerate, researchers discover 2Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3
... Their growths also tend to be on the right side, requiring ... -- Among Hispanics, men are twice as likely as women to ... polyps, a new study in Puerto Rico has found. , The ... 56 percent more likely to have polyps than those younger than ...
... ... endometriosis, diagnosis and treatment options. , ... (PRWEB) May 2, 2010 -- The Endometriosis Foundation of America (EFA) ... Science of Endometriosis: Stem Cells to Radical Excision Surgery”, taking place in New York ...
... VANCOUVER, BRITISH COLUMBIA Reports have suggested that sleep ... (ASDs) are associated with challenging daytime behaviors. ... with ASD confirms these reports and will support the ... to improve behavior, according to researchers from Autism Speaks, ...
... ask children to fast overnight before a cholesterol test. New ... "Cholesterol testing can be very difficult for families," said Asheley ... presented Sunday, May 2 at the Pediatric Academic Societies (PAS) ... fast, this almost always means the child has to return ...
... majority of teens say they have never heard of acetaminophen ... with access to the label instructions despite having taken ... Medical Center Study assessing teens, health literacy. More than 60 ... heard of acetaminophen despite 21 percent of them having taken ...
... include Tylenol, Tylenol Plus, Motrin and Benadryl , SATURDAY, ... Friday recalled more than 40 of its liquid cold ... medications may not meet federal quality standards. , The ... Plus, Motrin, Zyrtec and Benadryl. These medications have been ...
Cached Medicine News:Health News:Colon Polyps More Common in Hispanic Men Than Women 2Health News:Endometriosis Foundation of America to Present Landmark Scientific Symposium in NYC 2Health News:Children may be able to eat before cholesterol test, study shows 2
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... FRANKLIN, Ohio , Jan. 15, 2014  A novel wearable ... it easy and painless for patients to self-inject prescription drugs ... of disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic ... expected to grow to $220B by 2018, according to analysts.   ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
... Sept. 29, 2011 A west coast secret is finally ... the way from Beverly Hills, California, a health and beauty ... ( www.endlessyouthandlife.com ).  A clinically tested dietary supplement is helping ... in less than 4 weeks of use.  Just a few ...
... Sept. 29, 2011 Terumo Americas Holdings, Inc., a ... anniversary of Terumo Corporation,s founding in 1921.  Terumo Corporation ... with $4 billion in annual sales and operations in ... Forbes magazine ranked Terumo Corporation 14th of the ...
Cached Medicine Technology:Beverly Hills Secret Now Helping People Across The Country 2Terumo Corporation, A Global Leader In Medical Device Technology, Celebrates 90th Anniversary 2Terumo Corporation, A Global Leader In Medical Device Technology, Celebrates 90th Anniversary 3
... Our variable volume Finnpipette ... in a high performance pipette. ... colour-coded volume range, ensures quality, ... identification of the volume range ...
A Biplane Pediatric TEE transducer....
Super High Density, multi-frequency, convex array transducer for scanning during craniotomies. Same footprint as the UST-987-7.5 but with stronger penetration for deep cavernous tumors and other deep...
... Super High Density, multi-frequency, linear ... the first company to introduce ... and, as a result, changed ... and true workhorse has withstood ...
Medicine Products: